Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Background Multiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relationship between Gal-3 and PAD.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Circulation Outcomes 64

Frontiers in Cardiovascular Medicine

APRIL 30, 2024

Peripheral artery disease (PAD) continues to increase in prevalence worldwide due to risk factors such as advanced age, diabetes mellitus, and obesity. Critical limb ischemia (CLTI) is the advanced form of PAD that can result in a lack of healing and limb loss as the most devastating consequence.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Interventional Cardiology Nursing Obesity 52

American College of Cardiology

MARCH 29, 2025

Semaglutide, compared to placebo, significantly improved walking distance, symptoms and quality of life in participants with symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D), according to results of the STRIDE study presented at ACC.25 25 in Chicago and simultaneously published in The Lancet.

Peripheral Arterial Disease 66

Peripheral Arterial Disease Quality of Life Outcomes Diabetes 66

DAIC

MARCH 14, 2025

tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

HCPLive

DECEMBER 2, 2024

Bob Ross, PA-C, shares expert insights on early PAD detection, updated guidelines, and practical tools to improve vascular health outcomes from CAPP 2024.

Peripheral Arterial Disease 59

Peripheral Arterial Disease Outcomes 59

Journal of Cardiovascular Pharmacology

MARCH 4, 2024

Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after coronary heart disease and stroke yet is widely underdiagnosed and undertreated. Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Blood Pressure Risk Factors Nursing 40

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Studies were included if they compared DCBA and POBA in PAD patients, focusing on primary outcomes such as target lesion revascularization (TLR), primary patency (PP), all-cause mortality (ACM), and amputation. Secondary outcomes included restenosis, late lumen loss (LLL), and major adverse events (MAE).ResultsSixteen

Angioplasty 52

Angioplasty Peripheral Arterial Disease Outcomes Research 52

DAIC

FEBRUARY 4, 2025

3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. Peripheral Artery Disease (PAD) is a chronic condition where plaquea sticky substance made of fat and cholesterolbuilds up in the arteries that carry blood to your legs.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Blood Pressure Risk Factors Diabetes 52

Circulation

JUNE 20, 2024

There is significant variability in the efficacy and safety of oral P2Y12 inhibitors, which are used to prevent ischemic outcomes in common diseases such as coronary and peripheral arterial disease and stroke. Circulation, Ahead of Print.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Circulation Stroke Strokes 105

DAIC

FEBRUARY 14, 2024

Given this dismal outcome, the prognosis of CLTI is worse than most cancers.3,4 The global burden of peripheral artery disease. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. The global burden of peripheral artery disease.

Heart Attack 111

Heart Attack Heart attacks Peripheral Arterial Disease Ischemia 111

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 10, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Peripheral artery disease (PAD) is an atherosclerotic condition that affects a growing number of individuals worldwide, with estimates exceeding 220 million.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Outcomes Circulation Research 40

Circulation

NOVEMBER 11, 2024

There are discrepancies in the literature regarding whether vorapaxar alleviates ischemic outcomes and increases bleeding in patients with peripheral arterial disease (PAD).Purpose:The Introduction:Vorapaxar is an inhibitor of protease-activated receptor-1 (PAR1) and primarily blocks thrombin mediated platelet activation.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Ischemia Hospital Outcomes 40

DAIC

MAY 1, 2024

We believe the tools, resources, and information shared at the meeting will provide the healthcare community with greater expertise to improve patient outcomes and also connect with their interventional cardiology colleagues,” said SCAI President George D. Dangas, MD, PhD, MSCAI , Icahn School of Medicine - Mt.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

The American Journal of Cardiology

AUGUST 5, 2024

Publication date: Available online 5 August 2024 Source: The American Journal of Cardiology Author(s): Sameh Sayfo, Zachary P. Rosol, David Fernandez Vazquez, Mufaddal Mamawala, Blake M. Bruneman, Sarah G. Weideman, Kennedy S. Adelman, Minseob Jeong, Bala Ramanan, Shirling Tsai, Nicolas W. Shammas, Peter P. Monteleone, Aravinda Nanjundappa, Hung B.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Stents Stent Outcomes 40

The American Journal of Cardiology

APRIL 1, 2025

Publication date: Available online 1 April 2025 Source: The American Journal of Cardiology Author(s): Michael Gao, Angelo Oliva, Raman Sharma, Frank Kalaba, Samantha Sartori, Serdar Farhan, Kenneth Smith, Birgit Vogel, Prakash Krishnan, George Dangas, Roxana Mehran, Annapoorna Kini, Samin Sharma

Peripheral Arterial Disease 40

Peripheral Arterial Disease Outcomes 40

DAIC

NOVEMBER 8, 2024

Procedures that previously required the use of two different devices can now be performed in a single procedure using a single device, simplifying workflows and procedures and potentially reducing the risk and improving outcomes for patients who might otherwise face multiple complex interventions. Patients will be followed for 12 months.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

Journal of the American Heart Association

JANUARY 3, 2024

1.02]) after adjustment for baseline factors.ConclusionsComorbid MVD is present in a large and growing number of patients with PAD and is associated with augmented risk for adverse outcomes. Compared with PAD‐only, PAD/MVD was associated with a higher risk for major amputation (odds ratio [OR], 1.30 [95% CI, 1.28–1.32]),

Peripheral Arterial Disease 40

Peripheral Arterial Disease Outcomes Risk Factors Hospital 40

The American Journal of Cardiology

MAY 2, 2024

Publication date: Available online 1 May 2024 Source: The American Journal of Cardiology Author(s): Nameer Ascandar, Joseph Hadaya, Nam Yong Cho, Konmal Ali, Yas Sanaiha, Peyman Benharash

Peripheral Arterial Disease 40

Peripheral Arterial Disease Hospital Outcomes 40

The American Journal of Cardiology

FEBRUARY 27, 2025

Publication date: Available online 26 February 2025 Source: The American Journal of Cardiology Author(s): Mary O. Whipple, Shujun Xu, Dongxue Zhang, Jack Guralnik, Bonnie Spring, Lu Tian, Diane Treat-Jacobson, Lihui Zhao, Michael H. Criqui, Mary M. McDermott

Peripheral Arterial Disease 40

Peripheral Arterial Disease Exercise Outcomes 40

American College of Cardiology

MARCH 13, 2024

In this week’s View, Dr. Eagle covers various blood pressure parameters and their predictability for peripheral arterial disease (PAD) and complications, then explores the five-year outcomes of leadless pacemakers.

Blood Pressure 56

Blood Pressure Pacemaker Peripheral Arterial Disease Heart Failure 56

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:16 July 29, 2024 — CorVascular , a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices.

Certification 111

Certification Peripheral Arterial Disease Cerebrovascular Disease Quality of Life 111

Circulation

NOVEMBER 11, 2024

This study investigates the association between VTRNA2-1 promoter methylation and clinical outcomes in PAD patients requiring revascularization.Hypothesis:VTRNA2-1 promoter methylation status is associated with clinical outcomes in PAD patients requiring revascularization.Methods:A total of 133 PAD patients requiring revascularization were enrolled.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40

DAIC

NOVEMBER 8, 2024

Venita Chandra, director of vascular surgery, Stanford University School of Medicine, showed that DA followed by DCB achieved a significantly lower provisional stent rate with comparable safety and efficacy outcomes compared to standard predilatation prior to DCB, making it a viable alternative for treating long and highly calcified lesions.

Stent 52

Stent Stents Angioplasty Peripheral Arterial Disease 52

CardiacWire

MAY 10, 2024

A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheral artery disease surgeries has a massive impact on coronary artery disease detection, treatments, and long-term outcomes.

Coronary Artery Disease 59

Coronary Artery Disease Peripheral Arterial Disease Ischemia Myocardial Infarction 59

DAIC

JANUARY 9, 2024

Improvements in outcomes following peripheral vascular intervention have lagged compared to other endovascular treatments, such as percutaneous coronary intervention. Ongoing collaboration among these specialties is paramount to improving outcomes for patients worldwide.” Tam, MD, MBA, FSIR.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology 105

Circulation

DECEMBER 14, 2023

Furthermore, due to increasing patient complexity of management secondary to comorbid conditions, such as cardiovascular disease, the management of peripheral artery disease associated with DFUs has become increasingly difficult, and care delivery is often episodic and fragmented.

Diabetes 76

Diabetes Peripheral Arterial Disease Health Disparities Cardiovascular Disease 76

Journal of the American Heart Association

MARCH 27, 2025

The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

DAIC

MARCH 20, 2024

CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally. The Freesolve BTK RMS is designed for individuals suffering from chronic limb-threatening ischemia (CLTI). For more information: www.biotronik.com References: 1 Kwong M.,

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronary artery bypass grafting (CABG). 2.69], age (HR = 1.35, 95% CI 1.09–1.67,

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease 64

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. 23), which was not associated with better/worse clinical outcomes in patients with prior CABG.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

Heart BMJ

MARCH 12, 2024

The study aims to evaluate the applicability in the real world of randomised clinical trials (RCT) on antithrombotic treatment in patients with cardiovascular disease (CVD) and peripheral artery disease (PAD).

Peripheral Arterial Disease 52

Peripheral Arterial Disease Myocardial Infarction Heart attacks Heart Attack 52

Journal of the American Heart Association

MARCH 4, 2025

An increasing number of studies have shown the impact of social determinants of health (SDoHs) on different cardiovascular outcomes. In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40

Circulation

OCTOBER 18, 2023

BACKGROUND:Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) trial.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Myocardial Infarction Thrombolysis Ischemia 40

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 6, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Patients who had an myocardial infarction, underwent coronary artery bypass graft (hazard ratio, 1.60 [95% CI, 1.55–1.65]),

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Outpatient Peripheral Arterial Disease Cardiovascular Disease 45

Science Daily - Heart Disease

FEBRUARY 16, 2024

Researchers analyzed more than 145 million records covering every adult patient admitted to hospital in England over a nine-year period to establish the risk of long-term health outcomes following a heart attack -- in the largest study of its kind.

Heart Attack 44

Heart Attack Heart attacks Peripheral Arterial Disease Atrial Fibrillation 44

European Journal of Heart Failure

DECEMBER 10, 2024

Then identified clusters are predicted and tested in the learning set to evaluate their association with outcomes. Clusters were significantly associated with outcomes in derivation and validation datasets, with Cluster 1 having the highest risk, and Cluster 4 the lowest.

Heart Failure 40

Heart Failure Peripheral Arterial Disease Blood Pressure Atrial Fibrillation 40